L. Lee

发表

A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

D. Price, K. Harrington, K. Ladell, 2014, Clinical Cancer Research.

Electroglottogram approximate entropy: a novel single parameter for objective voice assessment.

Kathiresan Manickam, Jarrod J Homer, Nicholas J Slevin, 2010, The Journal of laryngology and otology.

Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

J. Homer, N. Slevin, R. Swindell, 2015, Head & neck.

Inter-fraction robustness of Intensity-Modulated proton therapy in the Post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas.

Lei Dong, M. V. van Herk, M. Aznar, 2019, The British journal of radiology.

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.

C. Faivre-Finn, F. Blackhall, N. Thatcher, 2008, Clinical lung cancer.

Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma

C. Rowbottom, G. Betts, N. Slevin, 2015, Acta oncologica.

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

T. Illidge, C. West, G. Betts, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.

N. Slevin, A. McPartlin, L. Lee, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.

C. Faivre-Finn, P. Lorigan, F. Blackhall, 2011, Lung cancer.

A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.

A. Molassiotis, W. Ryder, N. Slevin, 2012, The British journal of oral & maxillofacial surgery.

Baseline MD Anderson Symptom Inventory Score is Strongly Associated With Patient-reported Acute and Late Toxicity Following (Chemo) Radiotherapy for Head and Neck Cancers.

G. Price, A. McPartlin, L. Lee, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

A challenging presentation of invasive nasopharyngeal sarcomatoid carcinoma

L. Lee, V. Kaushik, H. Saeed, 2019, BMJ Case Reports.

Relative plan robustness of step-and-shoot vs rotational intensity-modulated radiotherapy on repeat computed tomographic simulation for weight loss in head and neck cancer.

C. Rowbottom, N. Slevin, W. Beasley, 2016, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.

Carl Rowbottom, T. Marchant, C. Moore, 2012, International journal of radiation oncology, biology, physics.

Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk

Nicholas Slevin, Carl Rowbottom, Adam Henry Aitkenhead, 2014, Radiation oncology.

Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring.

M. V. van Herk, C. West, N. Slevin, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Conventional fractionation should not be the standard of care for T2 glottic cancer

N. Slevin, L. Lee, C. Douglas, 2017, Radiation oncology.

Comprehensive Quantitative Evaluation of Inter-observer Delineation Performance of MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study

A. Garden, C. Fuller, I. Poon, 2022, medRxiv.

Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer.

C. Faivre-Finn, R. Swindell, L. Lee, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

J. Fowler, N. Slevin, L. Lee, 2009, Acta oncologica.

Comprehensive Quantitative Evaluation of Variability in MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.

A. Garden, C. Fuller, I. Poon, 2022, International journal of radiation oncology, biology, physics.

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

E. Miles, C. Nutting, J. Langendijk, 2022, Clinical and translational radiation oncology.

Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus

M. V. van Herk, A. McWilliam, C. West, 2018, Acta oncologica.

Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status

C. West, J. Homer, N. Slevin, 2018, Journal of Cancer Research and Clinical Oncology.

Dysphagia At 1 Year is Associated with Mean Dose to The Inferior Section of The Brainstem.

M. V. van Herk, E. V. Vasquez Osorio, A. McPartlin, 2022, International journal of radiation oncology, biology, physics.

Electronic Patient Reported Outcomes significantly improved toxicity data collection and were acceptable to both patients and clinicians in lung cancer radiotherapy outpatient clinics.

J. Kennedy, L. Lee, N. Bayman, 2017 .

Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy

Adam Henry Aitkenhead, R. Mackay, M. Aznar, 2022, The British journal of radiology.

Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre.

G. Betts, J. Homer, N. Slevin, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy.

R. Cowan, J. Logue, C. Mcbain, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).

J. Irlam, G. Betts, H. Mistry, 2023, Journal of Clinical Oncology.

Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem

M. V. van Herk, E. V. Vasquez Osorio, A. McPartlin, 2023, International journal of radiation oncology, biology, physics.